drugset / Trial / NCT02604992
Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
The primary objective of this study is to evaluate the comparative bioavailability of a test product of dronabinol oral solution administered under fed conditions to the reference listed drug (RLD) administered to participants under fed and fasted conditions. The secondary objective is to compare the onset of detectable dronabinol concentrations between dronabinol oral solution and the RLD.
Timeline
- Start
- 2015-11
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 4.25 mg | Oral |
| Subject | Dronabinol | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.